메뉴 건너뛰기




Volumn 113, Issue 3, 2013, Pages 1877-1903

Therapeutic benefits from nanoparticles: The potential significance of nanoscience in diseases with compromise to the blood brain barrier

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD-BRAIN BARRIER; CHEMICAL PROCESS; DISEASE STATE; IMPLANTABLE MATERIALS; PUBLIC INTEREST; SURFACE AREA; THERAPEUTIC BENEFITS; VASCULAR STRUCTURES;

EID: 84875154058     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/cr200472g     Document Type: Review
Times cited : (181)

References (426)
  • 300
  • 301
    • 0037119577 scopus 로고    scopus 로고
    • Miller, G. Science 2002, 297, 1116
    • (2002) Science , vol.297 , pp. 1116
    • Miller, G.1
  • 391
    • 84875146599 scopus 로고    scopus 로고
    • http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm089765.htm.
  • 398
    • 77953666882 scopus 로고    scopus 로고
    • Nanotechnology for in vitro neuroscience
    • Cooper, D. R.; Nadeau, J. L. Nanotechnology for in vitro neuroscience Nanoscale 2009, 1, 183
    • (2009) Nanoscale , vol.1 , pp. 183
    • Cooper, D.R.1    Nadeau, J.L.2
  • 404
    • 84869498477 scopus 로고    scopus 로고
    • in press (DOI: 10.1016/j.jconrel.2012.04.044)
    • Krol, S.: J. Controlled Release 2012, in press (DOI: 10.1016/j.jconrel. 2012.04.044).
    • (2012) J. Controlled Release
    • Krol, S.1
  • 418
    • 84869498477 scopus 로고    scopus 로고
    • in press, DOI: 10.1016/j.jconrel.2012.04.044
    • Krol, S. J. Controlled Release 2012, in press, DOI: 10.1016/j.jconrel. 2012.04.044.
    • (2012) J. Controlled Release
    • Krol, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.